Abstract
Epidemiology, and End Results (SEER) Program and the New York State Cancer Registry in the United States between 1992-2007. Blood 116:382, 2010 (suppl; abstr 872) 24. Au WY, Kumana CR, Kou M, et al: Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia. Blood 102:407-408, 2003 25. Siu CW, Au WY, Yung C, et al: Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: Implications for longterm cardiac safety. Blood 108:103-106, 2006
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
